greeksoup/ stock research

Omega Healthcare Investors (OHI) FY2014 results: revenue $505 million, up 20.6% on the year

Omega Healthcare Investors Inc. (OHI) reported revenue of $505 million for fiscal 2014, the year ended 31 December 2014, up 20.6% on the year before. Net income was $221 million, up 28.3%, and diluted earnings per share $1.74. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2015.

Revenue
$505 million
+20.6% on the year
FY2008FY2014
Operating margin
68.4%
63.5% a year earlier
FY2008FY2014
Net income
$221 million
+28.3% on the year
FY2008FY2014
Diluted EPS
$1.74
+19.2% on the year
FY2008FY2014

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2014FY2013FY2012On the yearLast 8 years
Revenue505419350+20.6%
Operating income345266215+30.0%
Operating margin68.4%63.5%61.3%
Interest expense11910095.5+18.9%
Pre-tax income221173n/a+28.3%
Net income221173121+28.3%
Net margin43.8%41.2%34.4%
Diluted EPS$1.74$1.46$1.12+19.2%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2014FY2013FY2012On the yearLast 8 years
Operating cash flow338280208+20.6%
Capital expenditure17.931.329.4-42.8%
Free cash flow320249179+28.6%
Free cash flow margin63.3%59.4%51.0%
Cash from investing-548-599-391
Cash from financing212320184-33.6%
Depreciation and amortisation123129113-4.2%
Share-based compensation8.65.95.9+44.6%
Dividends paid259218182+18.5%
Dividend per share$2.02$1.86$1.69+8.6%
Diluted shares, weighted127m118m108m+7.8%
Shares outstanding at period end128m124m112m+3.3%

Balance sheet

$ millionFY2014FY2013FY2012On the yearLast 8 years
Shareholders' equity1,4011,3001,011+7.8%
Debt2,3792,0241,825+17.5%
Other liabilities142138146+3.0%
Total liabilities and equity3,9223,4622,982+13.3%
Cash and equivalents4.52.61.7+71.6%
Other assets3,9173,4602,980+13.2%
Total assets3,9223,4622,982+13.3%

10-K for the year ended 31 December 2014, filed 27 February 2015: the filing.